These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17914921)

  • 1. Combination antifungals: an update.
    Segal BH; Steinbach WJ
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision making in antifungal monotherapy versus combination therapy.
    Lewis RE
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):61S-67S. PubMed ID: 16716124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungicidal versus Fungistatic: what's in a word?
    Lewis JS; Graybill JR
    Expert Opin Pharmacother; 2008 Apr; 9(6):927-35. PubMed ID: 18377336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward more effective antifungal therapy: the prospects of combination therapy.
    Kontoyiannis DP; Lewis RE
    Br J Haematol; 2004 Jul; 126(2):165-75. PubMed ID: 15238137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on antifungal treatment of invasive Candida and Aspergillus infections.
    Maschmeyer G; Ruhnke M
    Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in antifungal chemotherapy.
    Petrikkos G; Skiada A
    Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination antifungal therapy: a critical review of the evidence.
    Ostrosky-Zeichner L
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():65-70. PubMed ID: 18430131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric antifungal therapy. Part I: focus on febrile neutropenia, invasive aspergillosis, combination antifungal therapy and invasive candidiasis in immunocompromised pediatric patients.
    Allen U; Bow E; Doyle J; Richardson S; Robinson J; Rotstein C; Davies D; Hui C; Le Saux N; Laverdiere M; Read S
    Minerva Pediatr; 2010 Feb; 62(1):57-69. PubMed ID: 20212399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida resistance and its clinical relevance.
    Klepser ME
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):68S-75S. PubMed ID: 16716125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infections in the immunocompromised host.
    Hawkins C; Armstrong D
    Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.
    Steinbach WJ; Stevens DA
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S157-87. PubMed ID: 12975751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy for invasive mycoses: evaluation of past clinical trial designs.
    Sobel JD
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S224-7. PubMed ID: 15546122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandins: a wealth of choice--how clinically different are they?
    Zaas AK
    Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates.
    Kantarcioglu AS; Yucel A; Vidotto V
    J Chemother; 2003 Jun; 15(3):296-8. PubMed ID: 12868560
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.